title: Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab.
authors.affiliation: Department of Hematology/Oncology, Wakayama Medical University, 811-1 Kimi-idera, Wakayama, 633-1611, Japan. sonoki@wakayama-med.ac.jp.
authors.forename: Takashi
authors.initials: T
authors.lastname: Sonoki
authors.affiliation: 2nd Department of Pathology, Wakayama Medical University, Wakayama, Japan.
authors.forename: Yaqiong
authors.initials: Y
authors.lastname: Li
authors.affiliation: Tenri Institute of Medical Research, Nara, Japan.
authors.forename: Setsuko
authors.initials: S
authors.lastname: Miyanishi
authors.affiliation: Division of Pathology and Immunology, Kansai University of Health Sciences, Osaka, Japan.
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Nakamine
authors.affiliation: Department of Hematology/Oncology, Wakayama Medical University, 811-1 Kimi-idera, Wakayama, 633-1611, Japan.
authors.forename: Nobuyoshi
authors.initials: N
authors.lastname: Hanaoka
authors.affiliation: Department of Hematology/Oncology, Wakayama Medical University, 811-1 Kimi-idera, Wakayama, 633-1611, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Matsuoka
authors.affiliation: 2nd Department of Pathology, Wakayama Medical University, Wakayama, Japan.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Mori
authors.affiliation: Department of Hematology/Oncology, Wakayama Medical University, 811-1 Kimi-idera, Wakayama, 633-1611, Japan.
authors.forename: Hideki
authors.initials: H
authors.lastname: Nakakuma